Breathing Labs
Home
How To Start
Products
Breathing+ Package
Toys Package
Q&A
Login

PULMONARY DISEASES

6Mar

UC Davis Asthma Network hosts first annual Asthma Bootcamp

Posted by: admin Categories: PULMONARY DISEASES
Comments Off on UC Davis Asthma Network hosts first annual Asthma Bootcamp

(SACRAMENTO) About 100 patients, caregivers and health care clinicians gathered at the UC Davis Health Education Building on Saturday for UC Davis Asthma Network’s (UCAN™) first-ever Asthma Bootcamp. The free event, which was open to the public, educated people 12 years and older living with asthma, and their parents or home healthcare guardians on strategies […]

Read more
Tags:
6Mar

Chattanooga Salt Cavern Offers Treatment for Allergies, Asthma, Bronchitis And Other Lung Issues

Posted by: admin Categories: PULMONARY DISEASES
Comments Off on Chattanooga Salt Cavern Offers Treatment for Allergies, Asthma, Bronchitis And Other Lung Issues

Proprietor Rachel Shahen announces Chattanooga Salt Cavern will open on Saturday at 3800 St. Elmo Ave., near the Incline Railway at the foot of Lookout Mountain.   Officials said, “Guests coming to Chattanooga Salt Cavern will enter a spa-like salt room for sessions to breathe in microscopic salt particles that are proven to improve breathing.  The […]

Read more
Tags:
6Mar

Chattanooga Salt Cavern Opens, Offers Halotherapy for Improved Lung Health & Skin Conditions

Posted by: admin Categories: PULMONARY DISEASES
Comments Off on Chattanooga Salt Cavern Opens, Offers Halotherapy for Improved Lung Health & Skin Conditions

Chattanooga, Tennessee, is now home to a unique wellness destination, the Chattanooga Salt Cavern, which officially opens its doors this Saturday at 3800 St. Elmo Ave. Proprietor Rachel Shahen has announced that the new facility aims to provide a spa-like experience with a focus on halotherapy, a treatment designed to improve lung health and skin […]

Read more
Tags:
6Mar

COVID-19 pandemic changed all-cause mortality among US Latinos

Posted by: admin Categories: PULMONARY DISEASES
Comments Off on COVID-19 pandemic changed all-cause mortality among US Latinos

A new analysis of all-cause mortality of Hispanic and Latino adults published in Annals of Internal Medicine shows Mexicans and Central Americans were most affected by the pandemic. The study was based on trends seen among 15,568 adults aged 18 to 74 years who participated in the HCHS/SOL (Hispanic Community Health Study/Study of Latinos). Baseline […]

Read more
Tags:
6Mar

ASLAN Pharmaceuticals Bolsters COPD Fight with Top Experts and Promising Eblasakimab Data

Posted by: admin Categories: PULMONARY DISEASES
Comments Off on ASLAN Pharmaceuticals Bolsters COPD Fight with Top Experts and Promising Eblasakimab Data

In a significant stride towards revolutionizing Chronic Obstructive Pulmonary Disease (COPD) treatment, ASLAN Pharmaceuticals Ltd. has unveiled promising translational data from a comparative study of eblasakimab and dupilumab. This development, coupled with the enlistment of renowned respiratory experts Dr. Ramaswamy Krishnan and Dr. Reynold Panettieri to its Scientific Advisory Board, has positioned eblasakimab as a […]

Read more
Tags:
6Mar

Lower Allergy and Asthma Risk in Puerto Rican Children, Study Finds

Posted by: admin Categories: PULMONARY DISEASES
Comments Off on Lower Allergy and Asthma Risk in Puerto Rican Children, Study Finds

In the bustling corridors of day cares across Puerto Rico, amidst the cacophony of children’s laughter and playful shouts, a groundbreaking study has unfolded, offering new insights into the battle against allergies and asthma. At the heart of this research, presented at the annual American Academy of Allergy, Asthma & Immunology meeting in Washington, D.C., […]

Read more
Tags:
6Mar

ASLAN Pharmaceuticals Announces New Translational Data on Eblasakimab in COPD and Appoints Leading Respiratory Experts as Scientific Advisors

Posted by: admin Categories: PULMONARY DISEASES
Comments Off on ASLAN Pharmaceuticals Announces New Translational Data on Eblasakimab in COPD and Appoints Leading Respiratory Experts as Scientific Advisors

ASLAN PHARMACEUTICALS LIMITED New translational data from a head-to-head study of eblasakimab and dupilumab in a human tissue model of COPD shows eblasakimab performed better than dupilumab in improving airway function and enhancing bronchodilation at the same concentrations Leading respiratory experts, Ramaswamy Krishnan, PhD, and Reynold Panettieri, MD, appointed as scientific advisors to provide strategic […]

Read more
Tags:
6Mar

Revealed: The world’s most polluted cities – with Hanoi topping the list

Posted by: admin Categories: PULMONARY DISEASES
Comments Off on Revealed: The world’s most polluted cities – with Hanoi topping the list

Scientists have identified the world’s most polluted cities, whose residents are most at risk of inhaling toxic particles. At the top of the 100-strong list is the Vietnamese capital Hanoi, the only city with air pollution levels described as “very unhealthy”. In the densely populated capital, levels of a key pollutant linked to heart disease, […]

Read more
Tags:
6Mar

Anti-IL-5 Asthma Drug Data Show Potential Rise in Incomplete Therapeutic Effects

Posted by: admin Categories: PULMONARY DISEASES
Comments Off on Anti-IL-5 Asthma Drug Data Show Potential Rise in Incomplete Therapeutic Effects

A review of safety data and profiles of anti-interleukin-5 (IL-5) biologics used in eosinophilic asthma showed a potential rise in incomplete therapeutic effects, a finding that could adversely affect the benefit-risk profile of these drugs. This was among the findings of a systematic review and meta-analysis published in BMC Pulmonary Medicine. Investigators conducted a systematic […]

Read more
Tags:
6Mar

Cat Wheezing: Our Vet Explains What Is It, Why It Happens & When to See a Vet

Posted by: admin Categories: PULMONARY DISEASES
Comments Off on Cat Wheezing: Our Vet Explains What Is It, Why It Happens & When to See a Vet

The information is current and up-to-date in accordance with the latest veterinarian research. Learn more » You’ve slowly been noticing that your cat’s breathing has changed. It seems more like a wheeze, but you’re unsure if you should be concerned. Let’s look at some reasons why cats wheeze and when you should go to the […]

Read more
Tags:
6Mar

How Tennessee’s CHAMP Program is Transforming Asthma Care for Children

Posted by: admin Categories: PULMONARY DISEASES
Comments Off on How Tennessee’s CHAMP Program is Transforming Asthma Care for Children

In the heart of Tennessee, a groundbreaking initiative is making strides in the fight against childhood asthma. The Changing High-Risk Asthma in Memphis through Partnership (CHAMP) program, spearheaded by Le Bonheur Children’s Hospital, is lighting a beacon of hope for families grappling with the severe impacts of this chronic condition. By weaving together medical expertise, […]

Read more
Tags:
6Mar

Study Reveals Growing Air Pollution Health Disparities Among Racial and Ethnic Communities in the US

Posted by: admin Categories: PULMONARY DISEASES
Comments Off on Study Reveals Growing Air Pollution Health Disparities Among Racial and Ethnic Communities in the US

Imagine breathing in a lungful of air, hoping for the life-giving oxygen that sustains us all, but instead getting a mix of pollutants that could lead to asthma or even cut your life short. Now, imagine that the risk of this happening to you is significantly higher simply because of your race or ethnicity. This […]

Read more
Tags:
6Mar

Dr. David Yamane was awarded the Star Research Award at the 2024 Critical Care Congress for the presentation of the HYPERACT Study

Posted by: admin Categories: PULMONARY DISEASES
Comments Off on Dr. David Yamane was awarded the Star Research Award at the 2024 Critical Care Congress for the presentation of the HYPERACT Study

EXETER, N.H., March 6, 2024 /PRNewswire/ — Vapotherm, Inc. (OTCQX: VAPO), (“Vapotherm” or the “Company”) today announced that David Yamane, MD was awarded the Star Research Award by the Society for Critical Care Medicine (SCCM) at the 2024 Critical Care Congress. The award is in recognition of the HYPERACT study – a new multi-center, randomized […]

Read more
Tags:
6Mar

HYPERACT Study Compares Vapotherm High Velocity Therapy to NiPPV

Posted by: admin Categories: PULMONARY DISEASES
Comments Off on HYPERACT Study Compares Vapotherm High Velocity Therapy to NiPPV

The HYPERACT study, a groundbreaking multi-center, randomized, controlled trial, has recently unveiled its findings, comparing the effectiveness of non-invasive positive pressure ventilation (NiPPV) to Vapotherm high velocity therapy in treating moderate to severe exacerbations of COPD. This research marks a significant milestone in respiratory medicine, potentially altering the standard care for millions suffering from COPD. […]

Read more
Tags:
6Mar

Respiratory Disorders Treatment Market Anticipated to Grow at

Posted by: admin Categories: PULMONARY DISEASES
Comments Off on Respiratory Disorders Treatment Market Anticipated to Grow at

Respiratory disorders pose significant health challenges worldwide, affecting millions of individuals and placing a substantial burden on healthcare systems. The respiratory disorders treatment market encompasses a diverse array of therapies, medications, and interventions aimed at managing conditions such as asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis, and respiratory infections. This article explores the latest […]

Read more
Tags:
6Mar

Neighborhood disadvantage linked to poor quality of life in sleep-disordered breathing

Posted by: admin Categories: PULMONARY DISEASES
Comments Off on Neighborhood disadvantage linked to poor quality of life in sleep-disordered breathing

March 06, 2024 2 min read Add topic to email alerts Receive an email when new articles are posted on Please provide your email address to receive an email when new articles are posted on . “ data-action=”subscribe”> Subscribe We were unable to process your request. Please try again […]

Read more
Tags:
6Mar

ASLAN Pharmaceuticals (ASLN) Announces New Translational Data on Eblasakimab

Posted by: admin Categories: PULMONARY DISEASES
Comments Off on ASLAN Pharmaceuticals (ASLN) Announces New Translational Data on Eblasakimab

ASLAN Pharmaceuticals Ltd. (Nasdaq: ASLN), a clinical-stage, immunology focused biopharmaceutical company developing innovative treatments to transform the lives of patients, today announced new positive translational data from a head-to-head study of eblasakimab versus dupilumab in a human tissue model of chronic obstructive pulmonary disease (COPD) that provides further support for the potential of eblasakimab as […]

Read more
Tags:
6Mar

ASLAN Pharmaceuticals Announces New Translational Data on

Posted by: admin Categories: PULMONARY DISEASES
Comments Off on ASLAN Pharmaceuticals Announces New Translational Data on

New translational data from a head-to-head study of eblasakimab and dupilumab in a human tissue model of COPD shows eblasakimab performed better than dupilumab in improving airway function and enhancing bronchodilation at the same concentrations Leading respiratory experts, Ramaswamy Krishnan, PhD, and Reynold Panettieri, MD, appointed as scientific advisors to provide strategic counsel on eblasakimab’s […]

Read more
Tags:
6Mar

Tropheryma whipplei infection in the lung of a patient with long COVID: a case report | BMC Infectious Diseases

Posted by: admin Categories: PULMONARY DISEASES
Comments Off on Tropheryma whipplei infection in the lung of a patient with long COVID: a case report | BMC Infectious Diseases

A 62-year-old man presented with a 10-month history of dyspnea after COVID-19 infection. Dyspnea became worse in the month preceding presentation. Ten months earlier, he had taken a trip to Australia to visit his daughter, where he became infected with COVID-19. He had a fever and a slight cough. He had difficulty in breathing when […]

Read more
Tags:
6Mar

CDC updates COVID isolation guidelines: Vaccines, masks and symptoms

Posted by: admin Categories: PULMONARY DISEASES
Comments Off on CDC updates COVID isolation guidelines: Vaccines, masks and symptoms

Why COVID-19 nurse Lauren Leander who went viral burned out and quit ICU nurse Lauren Leander became a voice during the pandemic after a photo went viral. Burnout from the pandemic made her quit ICU nursing. Michael Chow, Arizona Republic Individuals who test positive for COVID-19 do not need to isolate themselves or stay at […]

Read more
Tags:
« Older posts
Newer posts »